Launching Combination Products: Brand extension and franchise development strategies report

A new report from Datamonitor

Datamonitor's Launching Combination Products: Brand extension and franchise development strategies report performs a comprehensive examination of current competitive pressures, best practices and future developments in key therapeutic areas including cardiovascular, respiratory, HIV and women's health.

Combination pharmaceutical products, or fixed-dose combinations (FDC's), offer benefits to many drug classes due to the additive nature of therapeutic effect and the reduced level of side-effects associated with their use. Their core advantage however is an improvement in convenience that stems from reducing prescription numbers and their associated administrative costs.

Although fixed-dose combination drugs have historically attracted disapproval from physicians, who typically prefer to determine the components and ratios of drug applications at their own discretion, a widespread acknowledgement and acceptance of these therapies has now been established. This is largely due to their effectiveness in areas such as HIV and asthma, but the successful positioning of combination products remains difficult in therapeutic areas where combination therapies only provide marginally incremental benefits.

Launching Combination Products is a new report published by Business Insights that provides detailed strategic guidance for the preparation and successful execution of combination product launches.

Detailed case studies also provide unique insights into the brand extension and franchise development strategies of leading companies and help to identify the key success factors behind recent combination product launches.

Discover potential growth opportunities for your brands, identify future combination launches and use case studies to understand the most effective launch strategies across key therapeutic areas with this new report.


Chapters include:

Executive Summary

Chapter 1 An introduction to combination products

Chapter 2 Strategies for cardiovascular products

Chapter 3 Strategies for respiratory products

Chapter 4 Strategies for diabetes products

Chapter 5 Strategies for HIV products

Chapter 6 Strategies for women's health products

Chapter 7 Strategies for other therapeutic areas

Chapter 8 Brand extension and franchise development strategies